United States v. Hitzig

63 F. App'x 83
CourtCourt of Appeals for the Fourth Circuit
DecidedApril 14, 2003
Docket01-4895
StatusUnpublished
Cited by2 cases

This text of 63 F. App'x 83 (United States v. Hitzig) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Hitzig, 63 F. App'x 83 (4th Cir. 2003).

Opinion

Affirmed by unpublished PER CURIAM opinion.

OPINION

PER CURIAM:

Pietr Hitzig appeals his judgment of conviction on thirty-four counts of illegally dispensing controlled substances in violation of 21 U.S.C. § 841(a)(1). He contends that the district court erred in instructing the jury and in considering his motions for judgment of acquittal because it did not require the government to prove, as an essential element of the crimes charged, that he did not have a legitimate medical purpose for dispensing the controlled substances. We disagree with his contention and, accordingly, affirm.

I

Hitzig was, at times pertinent to the case, a physician who was authorized by the United States to dispense controlled substances. 1 In 1992, Hitzig began pro *84 moting a medical protocol that he developed involving the combination of fenflura-mine and phentermine (“fen/phen”), both of which were approved by the FDA many years ago for use separately in the treatment of weight loss. By 1993, Hitzig’s practice was limited solely to prescribing fen/phen. Hitzig believed that the use of fen/phen would help balance certain chemicals in the brain (dopamine and serotonin), and he promoted his protocol as being a cure-all for most illnesses, including cancer, AIDS, psychiatric illness, asthma, lupus, multiple sclerosis, and Gulf War syndrome.

After a two-year investigation, which included undercover buys, the execution of federal search warrants, and review of thousands of pages of subpoenaed records, the government charged Hitzig under § 841(a)(1) with thirty-two counts of illegally dispensing phentermine and fenflu-ramine, one count of illegally dispensing oxycodone, and one count of illegally dispensing hydromorphone. All of these are controlled substances. These counts involved Hitzig’s interaction with twelve patients. For each of the counts, the government charged that Hitzig dispensed these controlled substances “not for a legitimate medical purpose in the usual course of professional medical practice and beyond the bounds of professional medical practice.”

Hitzig’s trial lasted approximately five weeks. The government presented the testimony of the patients referenced in the indictment (and/or their relatives), various physicians and medical personnel, law enforcement officers, members of Hitzig’s office staff, and other patients. The government also introduced into evidence many of Hitzig’s office records and patient medical records.

The evidence at trial established that Hitzig dispensed the controlled substances identified in the indictment. Moreover, the government’s expert witnesses testified that in doing so, Hitzig acted beyond the bounds of professional medical practice in numerous ways. According to these experts, Hitzig exceeded the bounds of professional medical practice by: failing to conduct physical examinations; failing to take adequate medical histories; failing to maintain a proper record of patients’ medical histories and treatments; failing to document medications given to patients; failing to document the bases for medicating patients; failing to administer baseline laboratory tests for assessing the condition of patients (e.g., EKG, blood chemistry panel, TB test for an alcoholic, urinalysis for a drug addict); failing to adequately monitor patients during the course of their treatment; directing patients with a history of drug abuse to self-regulate their medications; failing to document the toxic effects of prescribed medications; failing to advise patients that the use of fen/phen to treat conditions other than weight loss was experimental; using a rapid screening device for measuring psychiatric distress as a basis for diagnosing illness; excessively dosing patients beyond recommended levels without basis; continually advising patients to increase their medications in response to problems with the medications; and engaging in other improper conduct, such as violating rules of patient confidentiality by sharing patient medical information with others, encouraging patients to share medications, using drugs and alcohol in the presence of pa- *85 tiente, and engaging in inappropriate sexual behavior with patients.

Hitzig acknowledges that some of his patients “had seriously negative outcomes,” some “were not monitored aggressively enough” by him, and that he occasionally “interacted inappropriately with certain patients.” Brief of Appellant, at 10. Hitzig’s counsel conceded at oral argument that the government sufficiently proved that Hitzig’s conduct as charged in the indictment was beyond the bounds of professional medical practice. Nevertheless, Hitzig argues (as he did at trial) that his conduct, while perhaps unorthodox, was done in good faith as a physician.

Consistent with this theory, Hitzig moved for judgment of acquittal at the close of the government’s case-in-chief, arguing that the government had failed to prove (among other things) that he had acted without a legitimate medical purpose, which he contends is an essential element of the crimes for which he was indicted. The district court denied the motion, holding that the government was only required to prove (in addition to other elements) that Hitzig had acted either without a legitimate medical purpose or beyond the bounds of professional medical practice. Hitzig renewed his motion at the close of all of the evidence. The district court again denied the motion.

Hitzig requested that the district court instruct the jury that the government was required to prove that he acted without a legitimate medical purpose. However, the district court adhered to its prior determination that the government does not have this burden, and over Hitzig’s objection, it instructed the jury accordingly.

The jury convicted Hitzig on all counts. The district court sentenced him to concurrent terms of 45 months imprisonment on each count, to be followed by a term of 3 years supervised release, and imposed a special assessment of $3,800.00.

II

Section 841(a)(1) provides in pertinent part: “Except as authorized ..., it shall be unlawful for any person knowingly or intentionally to ... distribute, or dispense, ... a controlled substance.... ” We have set forth generally the elements necessary for conviction under this statute as being (1) a knowing or intentional attempt to distribute or dispense (2) a substance known to be controlled (3) in an unauthorized manner. United States v. Daniel, 3 F.3d 775, 778 (4th Cir.1993).

A.

We first address Hitzig’s contention that the district court erroneously instructed the jury. Hitzig challenges the jury instructions only as they pertain to the third of the § 841(a)(1) elements. He argues that the district court improperly instructed the jury in a manner that allowed it to convict him for conduct that might amount to medical malpractice, but does not rise to the level of criminality.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Perry Reese, III
442 F. App'x 8 (Fourth Circuit, 2011)
Hitzig v. United States
540 U.S. 905 (Supreme Court, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
63 F. App'x 83, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-hitzig-ca4-2003.